Imaging platform uses structured light to assess tissue oxygenation.
An imaging platform based on structured light that can measure oxygenation and hemoglobin levels in superficial tissue has now received FDA 510(k) clearance.
The Clarifi device, developed by California-based Modulated Imaging, employs spatial frequency domain imaging (SFDI), a near-infrared imaging approach providing quantitative determination of the optical properties and in vivo concentrations of chromophores over a wide field-of-view.
